A carregar...
Conditional Superagonist CTL Ligands for the Promotion of Tumor-Specific CTL responses
While it has been demonstrated that cytotoxic T lymphocytes (CTL) can be raised against tumor-associated self-antigens, achieving consistent and effective clinical responses has proven challenging. Superagonist altered peptide ligands (APL) can often elicit potent anti-tumor CTL responses where the...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3313650/ https://ncbi.nlm.nih.gov/pubmed/20483791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.0900448 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|